--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
ATOS Atossa Therapeutics
- 0.7249
- -0.0053-0.73%
Close Mar 18 16:00 ET
- 0.7600
- +0.0351+4.84%
Post 16:28 ET
91.19MMarket Cap-3.45P/E (TTM)
0.7669High0.7063Low598.23KVolume0.7274Open0.7302Pre Close438.70KTurnover0.48%Turnover RatioLossP/E (Static)125.80MShares2.310052wk High1.24P/B91.14MFloat Cap0.660052wk Low--Dividend TTM125.73MShs Float2231.9981Historical High--Div YieldTTM8.30%Amplitude0.5000Historical Low0.7330Avg Price1Lot Size
Atossa Therapeutics Key Stats
Atossa Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Atossa Therapeutics Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data